Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Charlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, Jannik Hilsted

    3 Citationer (Scopus)

    Abstrakt

    To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.
    OriginalsprogEngelsk
    TidsskriftScandinavian Journal of Clinical & Laboratory Investigation
    Vol/bind68
    Udgave nummer8
    Sider (fra-til)739-44
    Antal sider6
    ISSN0036-5513
    DOI
    StatusUdgivet - 2008

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart'. Sammen danner de et unikt fingeraftryk.

    Citationsformater